V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010145 | 330004437 | 1.48 | 38.6 | Curative (C) | 2014-06-10 | 2014-06-30 | CARBOPLATIN + PACLITAXEL | 2 | N | 330011960 | CARBOPLATIN + PACLITAXEL |
| 330010146 | 330004440 | 1.72 | 72.8 | Palliative (P) | 2014-04-18 | 2014-04-20 | CARBOPLATIN + PACLITAXEL | N | null | 330011962 | CARBOPLATIN + PACLITAXEL |
| 330010147 | 330004443 | 1.78 | 78 | null | 2018-03-07 | 2018-04-04 | Carbo F | 2 | N | 330011964 | CARBO + FLUOROURACIL |
| 330010148 | 330004446 | 0 | 48 | Curative (C) | 2013-10-09 | 2013-10-15 | EURAMOS TRIAL | 2 | N | 330011977 | EURAMOS TRIAL |
| 330010149 | 330010566 | 1.79 | 84 | null | 2018-04-16 | 2018-04-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330011981 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010150 | 330004451 | 1.8 | null | null | 2016-01-02 | 2016-01-07 | Cetuximab + Radiotherapy Maint | N | N | 330011983 | CETUXIMAB + RT |
| 330010151 | 330004452 | 1.6 | 54.9 | Palliative (P) | null | 2019-01-25 | CARBOPLATIN + PACLITAXEL | N | Y | 330011990 | CARBOPLATIN + PACLITAXEL |
| 330010152 | 330013041 | 0 | null | Curative (C) | 2016-03-18 | 2016-09-20 | EURAMOS TRIAL | null | null | 330012004 | EURAMOS TRIAL |
| 330010153 | 330004455 | null | 75 | Palliative (P) | null | 2016-02-04 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330012032 | CARBOPLATIN + PACLITAXEL |
| 330010154 | 330004456 | 0 | 85.2 | Palliative (P) | 2012-04-30 | 2013-03-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 330012034 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010155 | 330004458 | 1.59 | null | Curative (C) | 2016-11-10 | 2017-06-18 | CARBOPLATIN + RT | 2 | N | 330012037 | CARBOPLATIN + RT |
| 330010156 | 330004461 | null | 137 | Neo-adjuvant (N) | null | 2017-01-04 | EURAMOS TRIAL | null | null | 330012071 | EURAMOS TRIAL |
| 330010157 | 330004462 | 1.55 | null | Palliative (P) | 2015-10-13 | 2015-10-13 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 330012074 | UKALL2011 |
| 330010158 | 330004464 | 1.74 | 77.8 | Curative (C) | 2017-01-06 | 2017-04-05 | Cetuximab + Radiotherapy Maint | 02 | N | 330012077 | CETUXIMAB + RT |
| 330010160 | 330004465 | 1.66 | 75.3 | Neo-adjuvant (N) | 2016-08-23 | 2016-11-26 | CARBOPLATIN + FLUOROURACIL | 02 | N | 330012091 | CARBO + FLUOROURACIL |
| 330010161 | 330004468 | 1.78 | 69 | Palliative (P) | 2015-03-30 | 2015-04-26 | Paclitaxel (2 or 3 weekly) | 02 | null | 330012109 | PACLITAXEL |
| 330010162 | 330004472 | 1.84 | 9.7 | Disease modification (D) | null | 2014-09-18 | CARBOPLATIN + RT | N | null | 330012134 | CARBOPLATIN + RT |
| 330010163 | 330004472 | 0 | 77 | Curative (C) | 2016-09-11 | 2017-01-01 | Cetuximab + Radiotherapy Load | 02 | N | 330012134 | CETUXIMAB + RT |
| 330010164 | 330008440 | 1.61 | 73.2 | Disease modification (D) | 2016-10-22 | 2016-11-04 | EURAMOS TRIAL | N | Y | 330012145 | EURAMOS TRIAL |
| 330010165 | 330008442 | 1.69 | null | Palliative (P) | 2014-09-01 | 2017-06-20 | VAI (Ifos 3g/m2) | 02 | N | 330012165 | VAI |
| 330010166 | 330004479 | 1.74 | 78.2 | Palliative (P) | null | 2016-07-31 | Carbo F | null | null | 330012168 | CARBO + FLUOROURACIL |
| 330010167 | 330004480 | null | 104.65 | Palliative (P) | null | 2018-06-14 | CARBOPLATIN + FLUOROURACIL | N | null | 330012171 | CARBO + FLUOROURACIL |
| 330010168 | 330004481 | 1.06 | 112 | Palliative (P) | 2017-12-22 | 2018-07-12 | BENDAMUSTINE + RITUXIMAB | N | N | 330012172 | BENDAMUSTINE + RITUXIMAB |
| 330010169 | 330004482 | 1.6 | 44.2 | Neo-adjuvant (N) | 2018-07-21 | 2018-07-23 | EURAMOS TRIAL | 02 | N | 330012176 | EURAMOS TRIAL |
| 330010170 | 330004486 | 1.76 | 54 | Palliative (P) | 2013-07-13 | 2013-07-31 | CARBOPLATIN + FLUOROURACIL | 2 | null | 330012199 | CARBO + FLUOROURACIL |
| 330010171 | 330004488 | 1.63 | 78 | Neo-adjuvant (N) | 2016-10-07 | 2016-10-08 | Carboplatin + Etoposide IV 3 day | N | N | 330012203 | CARBOPLATIN + ETOPOSIDE |
| 330010172 | 330004490 | null | 83.4 | Neo-adjuvant (N) | 2018-03-05 | 2018-03-14 | VAI (Ifos 3g/m2) | N | null | 330012213 | VAI |
| 330010173 | 330004491 | 1.8 | 0 | null | null | 2013-06-22 | CETUXIMAB + RT | N | null | 330012214 | CETUXIMAB + RT |
| 330010174 | 330004494 | 0 | 63.6 | Palliative (P) | 2018-04-18 | 2018-04-19 | Cetuximab + Radiotherapy Maint | 02 | N | 330012228 | CETUXIMAB + RT |
| 330010175 | 330004496 | 1.89 | 100 | Curative (C) | 2016-05-10 | 2016-09-18 | EURAMOS TRIAL | N | N | 330012237 | EURAMOS TRIAL |
| 330010177 | 330004499 | 1.59 | null | Adjuvant (A) | 2014-07-17 | 2014-11-18 | VAI (Ifos 3g/m2) | N | N | 330012246 | VAI |
| 330010178 | 330004500 | 1.87 | 98 | Palliative (P) | 2016-10-08 | 2016-10-09 | CARBOPLATIN + FLUOROURACIL | N | N | 330012256 | CARBO + FLUOROURACIL |
| 330010179 | 330012432 | 1.83 | 86 | null | 2017-04-01 | 2017-11-22 | CARBOPLATIN + RT | 02 | N | 330012259 | CARBOPLATIN + RT |
| 330010180 | 330012810 | null | null | Palliative (P) | 2013-09-21 | 2013-11-30 | ALL UKALL2011 Maintenance A1 | N | null | 330012261 | UKALL2011 |
| 330010181 | 330010582 | 1.78 | 61 | Palliative (P) | 2019-02-09 | 2019-02-16 | PACLITAXEL | 02 | N | 330012272 | PACLITAXEL |
| 330010182 | 330004506 | null | 73 | Curative (C) | 2013-11-24 | 2014-01-18 | CETUXIMAB + RT | 2 | N | 330012277 | CETUXIMAB + RT |
| 330010183 | 330004509 | 1.75 | 82.9 | Curative (C) | 2013-11-05 | 2013-11-08 | CARBOPLATIN + ETOPOSIDE | 02 | N | 330012287 | CARBOPLATIN + ETOPOSIDE |
| 330010184 | 330004512 | null | 57.4 | Neo-adjuvant (N) | 2016-07-26 | 2016-07-26 | Bendamustine+Rituximab(Sub Courses) | null | null | 330012294 | BENDAMUSTINE + RITUXIMAB |
| 330010185 | 330004514 | 1.48 | 46 | Palliative (P) | 2013-10-27 | 2014-04-14 | Paclitaxel Priming | N | Y | 330012305 | PACLITAXEL |
| 330010186 | 330004517 | 1.57 | 98.5 | Palliative (P) | 2015-01-16 | 2015-05-12 | CARBOPLATIN + ETOPOSIDE | N | Y | 330012305 | CARBOPLATIN + ETOPOSIDE |
| 330010187 | 330004519 | 1.62 | 52 | Palliative (P) | 2015-08-22 | 2015-08-22 | Paclitaxel (2 or 3 weekly) | N | Y | 330012324 | PACLITAXEL |
| 330010188 | 330008464 | 1.7 | 63.7 | Palliative (P) | 2016-04-22 | 2016-07-05 | CARBOPLATIN + RT | null | null | 330012329 | CARBOPLATIN + RT |
| 330010189 | 330008465 | null | 63.15 | Adjuvant (A) | null | 2018-03-15 | Cetuximab + Radiotherapy Load | N | null | 330012345 | CETUXIMAB + RT |
| 330010190 | 330004526 | 1.75 | 50.2 | Curative (C) | null | 2014-12-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012347 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330010191 | 330008466 | 1.74 | null | Palliative (P) | 2015-09-19 | 2016-02-01 | VAI (Ifos 3g/m2) | 2 | N | 330012351 | VAI |
| 330010192 | 330010584 | null | null | Curative (C) | 2014-03-11 | 2014-03-15 | VAI (Ifos 3g/m2) | N | N | 330012352 | VAI |
| 330010193 | 330004531 | 1.63 | 63.3 | Palliative (P) | 2013-03-15 | 2013-03-15 | Bendamustine+Rituximab (1st Course) | 02 | Y | 330012357 | BENDAMUSTINE + RITUXIMAB |
| 330010194 | 330004532 | 1.6 | null | Palliative (P) | 2015-12-22 | 2015-12-22 | Carbo F | N | Y | 330012358 | CARBO + FLUOROURACIL |
| 330010195 | 330008470 | 1.79 | 82.5 | Curative (C) | 2013-10-23 | 2013-10-29 | ALL UKALL2011 Del Int C Recon PAsp | 02 | N | 330012360 | UKALL2011 |
| 330010196 | 330008470 | 1.66 | 62.2 | Curative (C) | 2014-11-16 | 2014-12-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012360 | CISPLATIN + DOCETAXEL + FLUOROURACIL |